SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-13-166116
Filing Date
2013-04-23
Accepted
2013-04-23 08:17:54
Documents
4
Group Members
ODYSSEUS ACQUISITION CORP.VALEANT PHARMACEUTICALS INTERNATIONAL

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A #5 d524196dsctota.htm SC TO-T/A 37555
2 EX-99.(A)(5)(F) d524196dex99a5f.htm EX-99.(A)(5)(F) 10418
3 GRAPHIC g524196g31z98.jpg GRAPHIC 18417
4 GRAPHIC g524196g39i75.jpg GRAPHIC 26459
  Complete submission text file 0001193125-13-166116.txt   112001
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806
Business Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806 562-628-1007
Obagi Medical Products, Inc. (Subject) CIK: 0001375247 (see all company filings)

IRS No.: 954658730 | State of Incorp.: DE | Fiscal Year End: 0710
Type: SC TO-T/A | Act: 34 | File No.: 005-82589 | Film No.: 13775210
SIC: 2834 Pharmaceutical Preparations